Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proto-oncogene protein C-Raf (RAF1) is a key MAP kinase kinase kinase (MAP3K) in the MAPK/ERK signaling pathway. It transmits signals from activated Ras proteins to downstream kinases MEK1 and MEK2, playing critical roles in cell growth, differentiation, survival, and apoptosis. Dysregulation or mutation can contribute to oncogenesis. Targeted therapeutics against RAF family members exist, but resistance mechanisms often emerge.
Inhibition of RAF kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene protein C-Raf (RAF1).